To determine the efficacy of citicoline in improving cerebral blood flow parameters and neurological status among neonates with hypoxic-ischemic encephalopathy using Doppler resistive index and Sarnat-Sarnat score after 72 hours of therapy.
All inborn neonates diagnosed with APGAR score (Table 2) less then 8/10 at 5 min of life presenting to the emergency room within the first day of life.
Outborn babies admitted in the last 24 hours with history or clinical features of perinatal asphyxia.
Neonates who have received therapeutic hypothermia
Neonates with congenital, developmental or chromosomal malformations
Significant antenatal risk factors leading to early-onset sepsis\DIC or CNS depression unrelated to asphyxia
Preterm neonates <35 weeks
Single group
Citicoline
DrugThis group will receive drug and standard care
Standard medical treatment
Other interventionThis group will receive only standard care
Sarnat and Sarnat scoring
Cerebral Resistive Index
Click on the lead sponsor to view all of their trials.
Khyber Girls Medical College
Lead sponsor
Hayatabad Medical Complex
Collaborator
This trial is not recruiting at the moment. You can still explore other options: